DPH.L Share News (DPH)
DPH Share
DPH Share
DPH Share
DPH Share
DPH
DPH Share
DPH Broker
DPH Directors
DPH Financial
DPH
DPH Short
DPH
(Alliance News) - Dechra Pharmaceuticals PLC on Monday reported higher full-year profit and revenue, though it warned that growth rates are normalising as pandemic tailwinds ease.
Read more(Alliance News) - Stocks in London were under pressure at the opening bell on Monday, as the mood turned sour on Friday evening after Russia shut off access to a key gas pipeline.
Read more(Alliance News) - Stocks in London are set to kick off the new week on the back foot, as Russia's move to stop gas deliveries to Europe is giving investors pause, amid growing fears of an energy crisis.
Read more
(Sharecast News) - Veterinary pharmaceuticals group Dechra said on Monday that both revenues and profits had risen throughout the twelve months ended 30 June.
Read more(Alliance News) - Stocks in London returned from the long weekend on Tuesday to close in the red despite spending most of the session in the green, as investors wiped out the morning's gains following selling pressure in the US.
Read more(Alliance News) - The FTSE 100 remained in the green on Tuesday at midday on account of a weaker pound, but gains ebbed as oil prices retreated from morning highs.
Read more(Alliance News) - Dechra Pharmaceuticals PLC on Tuesday said it has bought California-based veterinary pharmaceutical manufacturer Med-Pharmex Inc for USD260.0 million.
Read more(Alliance News) - Stock trading in London is set for a tepid start as UK market participants return from holiday on Tuesday, catching up with Monday's losses in Europe, as investors continue to mull over hawkish remarks from the head of the US central bank.
Read more(Sharecast News) - Dechra Pharmaceuticals said on Tuesday that it has bought California-based veterinary pharmaceutical manufacturer Med-Pharmex for $260m (£221.5m).
Read more(Alliance News) - Stocks in London ended higher on Thursday as investors digested another raft of corporate earnings, while the European Central Bank surprised markets with an aggressive rate hike.
Read more(Sharecast News) - Dechra Pharmaceuticals slumped on Thursday after the animal drug maker raised around £180m in a discounted share placing for the acquisition of US-based Piedmont Animal Health.
Read more(Alliance News) - Large-cap stocks in Europe struggled in early dealings on Thursday, as traders await a policy decision from the European Central Bank and after gas supplies through the critical Nord Stream pipeline restarted.
Read more(Alliance News) - Veterinary products firm Dechra Pharmaceuticals PLC on Thursday said it raised GBP184 million in a discounted share placing and subscription for its acquisition pipeline.
Read more(Alliance News) - Veterinary products firm Dechra Pharmaceuticals PLC on Wednesday said it is planning a fundraise for an acquisition, as it progresses talks for another potential buy.
Read moreDechra Pharmaceuticals PLC - veterinary products firm - Signs private placement of EUR50 million seven year and EUR100 million ten year senior unsecured notes. Weighted average coupon of the fixed rate notes will equate to 3.8%. Says issue has similar covenants to existing facilities. "The private placement is being undertaken now to achieve the group's aim of ensuring diversified sources of funding and to extend the group's debt maturity profile. All proceeds from the placement will be used to repay existing debt on the group's revolving credit facility." Dechra says.
Read more
